Last reviewed · How we verify
NCT03183401: DENACAPST
National Breast and Thyroid Screening After a Treatment Received Against a Cancer During Childhood
trial in Early Detection of Cancer in 2,000 participants. Status unknown.
31 October 2019
Quick facts
| Lead sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 9 July 2017 |
| Primary completion | 31 October 2019 |
| Estimated completion | 31 October 2019 |
| Sites | 1 location across France |
Conditions studied
- Early Detection of Cancer — all drugs for Early Detection of Cancer →
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France — full company profile →
Who can join
18 and older, any sex, with Early Detection of Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The DENACAPST programme represents an important initiative to provide near nation-wide roll-out of an important cancer surveillance program for childhood cancer survivors. The program is based on internationally recognized standards in cancer surveillance, which were developed by the International Guideline Harmonization Group (IGHG) with support of all relevant stakeholders in cancer survivorship research and clinical work in Europe, Canada and the United States and recognized French recommendations about breast screening for women at high risk of cancer. With this programme, French centers organized themselves to provide to childhood cancer survivors adequate medical attention, which includes close medical surveillance for breast/thyroid cancer where appropriate, based on adequate risk stratification. The aim of the study is to analyze if the recommendations about breast and thyroid cancer screening are followed in this population and secondly to provide more informations about these second cancers and about the screening.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03183401
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Early Detection of Cancer
Currently open trials in the same condition.
- NCT07118969 — A Quasi-Experimental Study to Improve Breast Cancer Awareness Among University Students · active not recruiting
- NCT03897374 — Strategic Targeting for Optimal Prevention of Cancer · recruiting
- NCT07106424 — Early Screening Cohort Study of Multiple Gastrointestinal Tumors · recruiting
- NCT06638554 — Integrating Telehealth to Advance Lung Cancer Screening · NA · recruiting
- NCT07224854 — Epigenetic Signature for CRC Early Detection · active not recruiting
Other Institut National de la Santé Et de la Recherche Médicale, France trials
Trials by the same sponsor.
- NCT07311213 — GENES AND AUTISM - IPSC · NA · not yet recruiting
- NCT07063719 — Identification of Cellular Biomarkers of Rare Eye Diseases in Adults · NA · not yet recruiting
- NCT06906042 — Multimodal Cardiovascular and Hepatic Population Imaging · recruiting
- NCT06951035 — Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke · NA · not yet recruiting
- NCT06660108 — MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03183401 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut National de la Santé Et de la Recherche Médicale, France
- Last refreshed: 21 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03183401.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing